Skip to content

Swedish biotech licenses HIV drug to China for development

More fixed dose ARVs for children needed urgently, says WHO

Abbott considered Norvir withdrawal before price hike option in 2003, documents show

Bevirimat, first maturation inhibitor: tablet formulation provides lower than expected plasma levels

GSK halts development of new PI, brecanavir

Prezista (darunavir) approved for treatment-experienced patients in Europe

HIV vaccine trials: measurements may overestimate participant understanding

Pfizer announces expanded access programme for maraviroc

HIV needs many more mutations to acquire resistance to darunavir